Back to User profile » Dr Lorie Ellis

Papers published by Dr Lorie Ellis:

Original Research

Comparative analysis of US real-world dosing patterns and direct infusion-related costs for matched cohorts of rheumatoid arthritis patients treated with infliximab or intravenous golimumab

Ellis LA, Malangone-Monaco E, Varker H, Stetsovsky D, Kubacki M, DeHoratius RJ, Kafka S

ClinicoEconomics and Outcomes Research 2019, 11:99-110

Published Date: 15 January 2019

Original Research

Analysis of real-world treatment patterns in a matched rheumatology population that continued innovator infliximab therapy or switched to biosimilar infliximab

Yazici Y, Xie L, Ogbomo A, Ellis LA, Goyal K, Teeple A, Simsek I

Biologics: Targets and Therapy 2018, 12:127-134

Published Date: 25 October 2018

Original Research

A descriptive analysis of real-world treatment patterns of innovator (Remicade®) and biosimilar infliximab in an infliximab-naïve Turkish population

Yazici Y, Xie L, Ogbomo A, Ellis LA, Goyal K, Teeple A, Mutlu EA, Simsek I

Biologics: Targets and Therapy 2018, 12:97-106

Published Date: 2 October 2018

Original Research

Shared decision-making for biologic treatment of autoimmune disease: influence on adherence, persistence, satisfaction, and health care costs

Lofland JH, Johnson PT, Ingham MP, Rosemas SC, White JC, Ellis L

Patient Preference and Adherence 2017, 11:947-958

Published Date: 18 May 2017